These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2191888)

  • 1. Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients.
    Benzi L; Trischitta V; Ciccarone A; Cecchetti P; Brunetti A; Squatrito S; Marchetti P; Vigneri R; Navalesi R
    Diabetes; 1990 Jul; 39(7):844-9. PubMed ID: 2191888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients.
    Trischitta V; Brunetti A; Chiavetta A; Benzi L; Papa V; Vigneri R
    Diabetes; 1989 Dec; 38(12):1579-84. PubMed ID: 2684714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of endosomal acidification in normal cells mimics the derangements of cellular insulin and insulin-receptor metabolism observed in non-insulin-dependent diabetes mellitus.
    Benzi L; Cecchetti P; Ciccarone AM; Nardone A; Merola E; Maggiorelli R; Campi F; Di Cianni G; Navalesi R
    Metabolism; 1997 Nov; 46(11):1259-65. PubMed ID: 9361682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects.
    Sesti G; D'Alfonso R; Vargas Punti MD; Tullio AN; Liu YY; Federici M; Borboni P; Marini MA; Lauro R; Fusco A
    Diabetologia; 1996 Mar; 39(3):289-95. PubMed ID: 8721774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.
    Wu MS; Johnston P; Sheu WH; Hollenbeck CB; Jeng CY; Goldfine ID; Chen YD; Reaven GM
    Diabetes Care; 1990 Jan; 13(1):1-8. PubMed ID: 2404714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients.
    Trischitta V; Gullo D; Pezzino V; Vigneri R
    J Clin Endocrinol Metab; 1983 Oct; 57(4):713-8. PubMed ID: 6350337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.
    Scheen AJ; Paolisso G; Salvatore T; Lefèbvre PJ
    Diabetes Care; 1991 Apr; 14(4):325-32. PubMed ID: 2060435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin internalization into monocytes is decreased in patients with type II diabetes mellitus.
    Trischitta V; Gullo D; Squatrito S; Pezzino V; Goldfine ID; Vigneri R
    J Clin Endocrinol Metab; 1986 Mar; 62(3):522-8. PubMed ID: 3944236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular insulin processing is altered in monocytes from patients with type II diabetes mellitus.
    Trischitta V; Benzi L; Brunetti A; Cecchetti P; Marchetti P; Vigneri R; Navalesi R
    J Clin Endocrinol Metab; 1987 May; 64(5):914-20. PubMed ID: 3549760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes.
    Nosadini R; Avogaro A; Trevisan R; Valerio A; Tessari P; Duner E; Tiengo A; Velussi M; Del Prato S; De Kreutzenberg S
    Diabetes Care; 1987; 10(1):62-7. PubMed ID: 3552515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production.
    Perriello G; Misericordia P; Volpi E; Santucci A; Santucci C; Ferrannini E; Ventura MM; Santeusanio F; Brunetti P; Bolli GB
    Diabetes; 1994 Jul; 43(7):920-8. PubMed ID: 8013758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
    Féry F; Balasse EO
    Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exercise intensity on glucose and insulin metabolism in obese individuals and obese NIDDM patients.
    Kang J; Robertson RJ; Hagberg JM; Kelley DE; Goss FL; DaSilva SG; Suminski RR; Utter AC
    Diabetes Care; 1996 Apr; 19(4):341-9. PubMed ID: 8729157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.